Therefore, GATA3 implementation enhances adipogenesis, modifies fat distribution, improves insulin sensitivity, and reduces obesity-related inflammation, supporting its therapeutic relevance in type 2 diabetes (T2D) pathology [19,20]. The gene discussed is GATA3; the disease is type 2 diabetes mellitus.